No Data
Craig-Hallum Maintains CareDx(CDNA.US) With Buy Rating
Craig-Hallum Keeps Their Buy Rating on CareDx (CDNA)
CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies
CareDx to Report Fourth Quarter and Full Year 2024 Financial Results
CareDx Shares Are Trading Higher After Chevy Chase Trust CIO Amy Raskin Disclosed on CNBC's Halftime Report That She Has Bought the Stock.
Express News | CareDx Shares Are Trading Higher After Chevy Chase Trust CIO Amy Raskin Disclosed on CNBC's Halftime Report That She Has Bought the Stock
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
